Reunion Neuroscience Inc. (REUN) Fundamentals

Field Trip is a global leader in the development and delivery of psychedelic therapies. With Field Trip Discovery, the company's research division, leading the development of the next generation of psychedelic molecules and conducting advanced research on plant-based psychedelics, and its Field Trip Health division building centers for psychedelic therapies across North America and Europe along with the digital and technological tools that will enable massive scale.
SHARE INFORMATION
Market Cap$ 21,425,140
Shares Outstanding11,645,152
Float7,602,016
Percent Float65.29%
Short Interest16,005.00
Short Percent Float100.0%
Short Interest Ratio0.930091
Short Interest Date2023-01-15
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 4,860,129
Latest Fiscal EPS$ -4.78
Latest Fiscal Date2022-03-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions46
Institutional Holdings Date2022-12-31
Institutional Bought Previous 3 Months53,458
Institutional Holdings Percent15.3%
Institutional Sold Previous 3 Months299,399
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned22,745,120
TRADING INFO
52 Week High$ 13.10
52 Week Low$ 1.08
52 Week High Change$ -84.98
21 Day Moving Average$ 1.7219
21 Day Extended Moving Average$ 1.7557
50 Day Moving Average$ 1.6976
50 Day Extended Moving Average$ 1.8565
200 Day Moving Average$ 3.9763
200 Day Extended Moving Average$ 5.1629
10 Day Average Volume7,058
20 Day Average Volume11,876
30 Day Average Volume10,186
50 Day Average Volume7,279
Alpha-0.08592
Beta3.84481
Standard Deviation0.286619
R20.308146
7 Day Price Change$ 0.08
7 Day Percent Change4.55%
21 Day Price Change$ 0.01
21 Day Percent Change0.55%
30 Day Price Change$ 0.61
30 Day Percent Change49.59%
Month to Date Price Change$ 0.65
Month to Date Percent Change54.62%
Quarter to Date Price Change$ 0.65
Quarter to Date Percent Change54.62%
180 Day Price Change$ -3.51
180 Day Percent Change-65.61%
200 Day Price Change$ -3.61
200 Day Percent Change-66.24%
Year to Date Price Change$ 0.65
Year to Date Percent Change54.62%

Reunion Neuroscience Inc. (REUN) Key Ratios

PROFITABILITY
EBIT Margin-1,188.9%
EBITDA Margin-1,120.1%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin-7.8%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 1,724,102
Revenue Per Share$ 0.148053
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.56
Total Debt To Equity0.05
Int Coverage-97.00
Current Ratio7.60
Leverage Ratio1.60
Quick Ratio7.00
Long Term Debt To Capital0.29
VALUATION MEASURES
PE Ratio-0.40
Enterprise Value$ -13,464,796
Price to Sales12.428
Price to Free Cash-0.50
PE High Last 5 Years0.00
Price To Book0.56
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book0.56
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.50
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-71.74
Return on Equity-90.45
Return on Capital-78.04

Reunion Neuroscience Inc. (REUN) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorErnst & Young LLP
CEOJoseph del Moral
Emplyoees194
Last AuditUQ
CIK0001865482
IndustryHealthcare Providers & Services
SectorHealthcare
NAICSOffices of Mental Health Practitioners (except Physicians)(621330)
CONTACT INFO
Address30 Duncan Street
Suite 401
Toronto, ON M5V 2C3
Websitehttps://www.fieldtriphealth.com
Facsimile+1 855 933-1211
Telephone+1 416 505-0929
Email-
Your Recent History
TSX
REUN
Reunion Ne..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20230129 15:46:34